title: Cost-Utility Analysis of Recommended Ranibizumab Regimen for Age-Related Macular Degeneration in China.
authors.affiliation: Fudan University, China, Shanghai, China.
authors.forename: X
authors.initials: X
authors.lastname: Ying
authors.affiliation: Fudan University, China, Shanghai, China.
authors.forename: S
authors.initials: S
authors.lastname: Feng
authors.affiliation: Fudan University, China, Shanghai, China.
authors.forename: W
authors.initials: W
authors.lastname: Wu
authors.affiliation: Beijing Novartis Pharma Co., Ltd, Beijing, China.
authors.forename: J
authors.initials: J
authors.lastname: Chang